APLS
Price
$23.16
Change
-$0.16 (-0.69%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
2.95B
28 days until earnings call
Intraday BUY SELL Signals
BLTE
Price
$182.36
Change
-$4.91 (-2.62%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
7.02B
51 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLS vs BLTE

Header iconAPLS vs BLTE Comparison
Open Charts APLS vs BLTEBanner chart's image
Apellis Pharmaceuticals
Price$23.16
Change-$0.16 (-0.69%)
Volume$42.58K
Capitalization2.95B
Belite Bio
Price$182.36
Change-$4.91 (-2.62%)
Volume$4.94K
Capitalization7.02B
APLS vs BLTE Comparison Chart in %
APLS
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
APLS vs. BLTE commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a StrongBuy and BLTE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (APLS: $23.32 vs. BLTE: $187.27)
Brand notoriety: APLS and BLTE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 86% vs. BLTE: 163%
Market capitalization -- APLS: $2.95B vs. BLTE: $7.02B
APLS [@Biotechnology] is valued at $2.95B. BLTE’s [@Biotechnology] market capitalization is $7.02B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileBLTE’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • BLTE’s FA Score: 0 green, 5 red.
According to our system of comparison, APLS is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 6 TA indicator(s) are bullish while BLTE’s TA Score has 4 bullish TA indicator(s).

  • APLS’s TA Score: 6 bullish, 3 bearish.
  • BLTE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APLS is a better buy in the short-term than BLTE.

Price Growth

APLS (@Biotechnology) experienced а +6.92% price change this week, while BLTE (@Biotechnology) price change was +11.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

APLS is expected to report earnings on Mar 04, 2026.

BLTE is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($7.02B) has a higher market cap than APLS($2.95B). BLTE YTD gains are higher at: 17.073 vs. APLS (-7.166). APLS has higher annual earnings (EBITDA): 93.4M vs. BLTE (-63.25M). APLS has more cash in the bank: 479M vs. BLTE (276M). BLTE has less debt than APLS: BLTE (510K) vs APLS (475M). APLS has higher revenues than BLTE: APLS (1.02B) vs BLTE (0).
APLSBLTEAPLS / BLTE
Capitalization2.95B7.02B42%
EBITDA93.4M-63.25M-148%
Gain YTD-7.16617.073-42%
P/E Ratio64.79N/A-
Revenue1.02B0-
Total Cash479M276M174%
Total Debt475M510K93,137%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSBLTE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 21 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signal:
Gain/Loss:
BLTE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBFAX18.580.16
+0.87%
VanEck Emerging Markets A
NSIVX12.320.04
+0.33%
North Square Altrinsic Intl Eq I
FNICX32.16N/A
N/A
Fidelity Advisor New Insights C
TIHBX15.96N/A
N/A
Transamerica International Stock I
MGORX35.11-0.72
-2.01%
Morgan Stanley Inst Global Opp IR

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+2.15%
DNLI - APLS
49%
Loosely correlated
-4.22%
ALPS - APLS
48%
Loosely correlated
-2.09%
DYN - APLS
43%
Loosely correlated
+1.07%
ARWR - APLS
40%
Loosely correlated
-1.18%
OCUL - APLS
40%
Loosely correlated
-6.99%
More

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+8.05%
RAIN - BLTE
48%
Loosely correlated
-1.53%
ACOG - BLTE
26%
Poorly correlated
+3.24%
AVTX - BLTE
23%
Poorly correlated
+1.98%
AGIO - BLTE
22%
Poorly correlated
-0.82%
APLS - BLTE
22%
Poorly correlated
+2.15%
More